- Headquarters
- Basel, Switzerland · Europe
- Value chain
- Medicines & vaccines(Products); also Chemicals & gases
- What that means
- Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
- Founded
- 1896
- Staff
- 103,600 (2024)
- Ownership
- Listed
- Listing
- SIX:ROG on Google Finance
- Website
- roche.com
- Relevance
- High at its strongest, in Genomics & Biological Data
In 2 capabilities
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Equipment & materials · listed #6 of 50
Major genomics patent holder supplying KAPA library-prep and target-enrichment chemistry and developing its Sequencing by Expansion (SBX) NGS platform.
Relevance: Major library-prep, enrichment and sequencing IP holder
Biotechnology & Health Technologies · Design · listed #8 of 50
Biologics leader (including Genentech) that produces Tamiflu and Xofluza influenza antivirals and is developing first-in-class antibiotics such as zosurabalpin.
Relevance: Biologics leader and antiviral producer